All In Biotech

Drug Trial Radar · NCT03455842

The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis

International Multicenter Comparative Randomized Double-blind Placebo-controlled Clinical Study of Efficacy and Safety of BCD-089 in Different Dosing Regimens in Patients With Active Rheumatoid Arthritis

Last checked: Nov 19, 2026Latest source record: Nov 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 105 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

105

Actual

Start

Feb 1, 2018

Primary completion

Dec 31, 2018

Study completion Oct 22, 2019

Sponsor

Lead sponsor
BiocadIndustry
Sponsor type
Industry
First posted
Mar 7, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is Phase II randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety, pharmacokinetics and pharmacodynamics of 2 dosing regimens (qw and q2w, s/c) of monoclonal antibody to IL6R (BCD-089) in patients with active rheumatoid arthritis and inadequate response to methotrexate.

Conditions

  • Seropositive RA

Interventions

  • BCD-089, 162 mg, s/c, qwBiological

    Subcutaneous injections of anti-IL6R every week

  • BCD-089, 162 mg, s/c, q2wBiological

    Subcutaneous injections of anti-IL6R every other week

  • placeboDrug

    Subcutaneous injections of placebo every week, until week 12. Thereafter subcutaneous injections of anti-IL6R every other week

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ACR20Time frame: week 12

Locations

4 sites in 2 countries. Site status is shown where the registry gives one.

  • 1st City Clinical Hospital

    Minsk, Belarus

  • Chelyabinsk Regional Clinical hospital

    Chelyabinsk, Russia

  • Kazan State Medical University

    Kazan', Russia

  • North-Western State Medical University n.a. I.I.Mechnikov

    Saint Petersburg, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.